ClpB-IN-1

CAS No. 1453172-23-0

ClpB-IN-1( —— )

Catalog No. M36349 CAS No. 1453172-23-0

ClpB-IN-1 is a potential antimicrobial agent.ClpB-IN-1 is a potent ClpB inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 51 Get Quote
10MG 85 Get Quote
25MG 158 Get Quote
50MG 254 Get Quote
100MG 401 Get Quote
500MG 896 Get Quote
1G 1197 Get Quote

Biological Information

  • Product Name
    ClpB-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    ClpB-IN-1 is a potential antimicrobial agent.ClpB-IN-1 is a potent ClpB inhibitor.
  • Description
    ClpB-IN-1 (compound 7) is a potent ClpB inhibitor. ClpB-IN-1 is a potential antibacterial agents.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1453172-23-0
  • Formula Weight
    302.37
  • Molecular Formula
    C14H10N2O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (16.54 mM; Ultrasonic (<60°C)
  • SMILES
    C=CCN1C(=S)S\C(C1=O)=C1/C(=O)Nc2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Martin I, et, al. Screening and evaluation of small organic molecules as ClpB inhibitors and potential antimicrobials. J Med Chem. 2013 Sep 26;56(18):7177-89.?
molnova catalog
related products
  • Sulfisoxazole acetyl

    Sulfisoxazole acetyl is an agent with antibacterial activity. Sulfisoxazole acetyl is a Sulfisoxazole derivative with antibacterial activity. Sulfisoxazole acetyl is an inhibitor of dihydropteroate synthase.

  • Sulfaproxiline

    Sulfaproxiline is a synthetic antibacterial drug of sulfonamide.

  • Ceftibuten dihydrate

    Ceftibuten dihydrate is the dihydrate form of ceftibuten, and is a third-generation cephalosporin with antibacterial activity.